Similarly, HOXD13 is overexpressed in NET G1 and NET G2 tumors, but downregulated in NET G3, and strongly down regulated in NEC G3 categories (Figure 1s–v; Figure 2d). The gene discussed is HOXD13; the disease is neuroendocrine carcinoma.